Actual Medicinal Product (AMP) -
Pabrinex Intravenous High Potency No.2 concentrate for solution for infusion 5ml ampoules (Kyowa Kirin International UK NewCo Ltd)
Name Details
Current Name
Pabrinex Intravenous High Potency No.2 concentrate for solution for infusion 5ml ampoules
|
Start Date
09-10-2024
|
End Date
|
Previous Name
Pabrinex Intravenous High Potency No.2 solution for injection 5ml ampoules
|
Start Date
21-01-2009
|
End Date
08-10-2024
|
|
Abbreviated Name
Pabrinex Intravenous High Potency No.2 concentrate for inf
|
Start Date
09-10-2024
|
|
Pabrinex Intravenous High Potency No.2 inj 5ml ampoules |
Previous Start Date
01-05-2009
|
Previous End Date
08-10-2024
|
Summary
- Licensed Route
- Intravenous
- Availability Restrictions
- None
- Licensing Authority
- Medicines - MHRA/EMA
- Combination Product
- Component Only Product
Codes
BNF |
Previous BNF
09060200
|
Start Date
28-06-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
8296811000001106 |
04-11-2004 |
|
Actual Medicinal Product Pack (AMPP) Information